Madeleine Foster, Chief Pharmaceutical Officer’s Clinical at SPS, presents a summary of the resources published by SPS between 19th and 25th July. 
To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter.    
Quick links to highlighted resources:     
Key principles on avoiding ingredients in medicines 
Spiritual, religious, cultural, and lifestyle factors can affect preferences for excipients and active ingredients in medicines. We cover key principles. 
https://www.sps.nhs.uk/articles/key-principles-on-avoiding-ingredients-in-medicines/ 
Avoiding animal contents within medicines  
Our guidance on supporting patients avoiding animal products, offers you informed, patient-centred decisions regarding animal containing or derived medicines. 
https://www.sps.nhs.uk/articles/avoiding-animal-contents-within-medicines/ 
Benzylpenicillin for Group B Streptococcus for use in neonates 
SPS PGD template for the intrapartum administration of benzylpenicillin for prevention of early-onset Group B Streptococcus (GBS) infection in neonates. 
https://www.sps.nhs.uk/articles/benzylpenicillin-for-group-b-streptococcus-for-use-in-neonates/ 
Terbutaline injection for use in labour within maternity services  
SPS PGD template for administering subcutaneous terbutaline sulfate for the reduction of contraction frequency in individuals in labour. 
https://www.sps.nhs.uk/articles/terbutaline-injection-for-labour-within-maternity-services/ 
Combined oral hormonal contraceptive (COC) in reproductive health  
SPS PGD template for the supply of a combined oral hormonal contraceptive for contraception, or for individuals requiring control of problematic bleeding. 
https://www.sps.nhs.uk/articles/combined-oral-hormonal-contraceptive-coc-in-reproductive-health/ 
Progestogen only pill (POP) for contraception 
SPS PGD template for the supply of a progestogen only pill (POP) for contraception. 
https://www.sps.nhs.uk/articles/progestogen-only-pill-pop-for-contraception/ 
Preparing to use aflibercept 2mg biosimilar 
Aflibercept 2mg biosimilars for use in ophthalmology are expected in December 2025 for NHS use. We offer general information and implementation advice. 
https://www.sps.nhs.uk/articles/preparing-to-use-aflibercept-2mg-biosimilar/ 
Next events – forthcoming webinars and conferences      
https://www.sps.nhs.uk/home/events/next-events/     
Podcast description:    
NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.